| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases....
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of 60 Degrees (NASDAQ:SXTP) through any online brokerage.
Other companies in 60 Degrees’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
60 Degrees has a consensus price target of $3.70.
The stock price for 60 Degrees (NASDAQ: SXTP) is $0.944307 last updated October 9, 2026 at 6:08 PM EDT.
There are no upcoming dividends for 60 Degrees.
60 Degrees does not have any upcoming earnings scheduled.
There is no upcoming split for 60 Degrees.
60 Degrees is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
